1. Home
  2. HALO vs FN Comparison

HALO vs FN Comparison

Compare HALO & FN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
    SELLHOLDBUYas of 11 hours ago
  • FN
    SELLHOLDBUYas of 11 hours ago
  • Stock Information
  • Founded
  • HALO 1998
  • FN 1999
  • Country
  • HALO United States
  • FN Cayman Islands
  • Employees
  • HALO N/A
  • FN N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • FN Telecommunications Equipment
  • Sector
  • HALO Health Care
  • FN Utilities
  • Exchange
  • HALO Nasdaq
  • FN Nasdaq
  • Market Cap
  • HALO 7.4B
  • FN 8.3B
  • IPO Year
  • HALO N/A
  • FN 2010
  • Fundamental
  • Price
  • HALO $62.27
  • FN $220.09
  • Analyst Decision
  • HALO Buy
  • FN Buy
  • Analyst Count
  • HALO 9
  • FN 8
  • Target Price
  • HALO $61.63
  • FN $247.88
  • AVG Volume (30 Days)
  • HALO 1.4M
  • FN 853.3K
  • Earning Date
  • HALO 05-06-2025
  • FN 05-05-2025
  • Dividend Yield
  • HALO N/A
  • FN N/A
  • EPS Growth
  • HALO 63.33
  • FN 29.03
  • EPS
  • HALO 3.43
  • FN 8.94
  • Revenue
  • HALO $1,015,324,000.00
  • FN $3,122,632,000.00
  • Revenue This Year
  • HALO $20.06
  • FN $20.88
  • Revenue Next Year
  • HALO $23.87
  • FN $13.11
  • P/E Ratio
  • HALO $18.14
  • FN $24.63
  • Revenue Growth
  • HALO 22.44
  • FN 14.83
  • 52 Week Low
  • HALO $37.73
  • FN $159.69
  • 52 Week High
  • HALO $65.53
  • FN $281.79
  • Technical
  • Relative Strength Index (RSI)
  • HALO 72.81
  • FN 54.72
  • Support Level
  • HALO $60.38
  • FN $176.99
  • Resistance Level
  • HALO $63.11
  • FN $228.96
  • Average True Range (ATR)
  • HALO 1.71
  • FN 13.34
  • MACD
  • HALO 0.16
  • FN 2.87
  • Stochastic Oscillator
  • HALO 86.47
  • FN 82.94

Stock Price Comparison Chart: HALO vs FN

HALO
FN
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025020406080100120140160180200220240260280HALO VS FN

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About FN Fabrinet

Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use